Fabrizio Conti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study	JOURNAL OF PERSONALIZED MEDICINE	2024
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2024
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor. a narrative review	MODERN RHEUMATOLOGY	2024
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort	REUMATISMO	2024
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus	JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM	2024
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations	JOURNAL OF CLINICAL MEDICINE	2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus	AUTOIMMUNITY REVIEWS	2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2024
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2024
Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C	FRONTIERS IN IMMUNOLOGY	2024
Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2024
Antibody profiles in the mosaic of "seronegative" APS syndrome	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2024
Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2024
Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival	RHEUMATOLOGY	2024
Belimumab 10 years later. how drug positioning has changed	IMMUNOLOGIC RESEARCH	2024
Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients. results from a cross-sectional analysis.	LUPUS	2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors.	REUMATISMO	2024
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	LUPUS	2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity	JOURNAL OF IMMUNOLOGY RESEARCH	2023

1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »

Progetti di Ricerca

MODULATION OF NEURO-IMMUNE INTERACTION THROUGH JAK INHIBITION IN RHEUMATOID ARTHRITIS
Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation.
Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine